Cargando…
Early Outpatient Treatment of SARS-CoV-2 (COVID-19): A Comment
Autores principales: | Korman, Tony M., McMahon, James H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901364/ https://www.ncbi.nlm.nih.gov/pubmed/33637180 http://dx.doi.org/10.1016/j.amjmed.2020.08.044 |
Ejemplares similares
-
Comment on: “Consensus of the major outpatient surgery section of the Spanish Association of Surgeons on the role of major outpatient surgery in the SARS-CoV-2 pandemic”()
por: Pinzón Bernal, Carla Yaneth, et al.
Publicado: (2022) -
Comment on: “Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence”
por: Mazza, Mario Gennaro, et al.
Publicado: (2022) -
Favipiravir and the Need for Early Ambulatory Treatment of COVID-19
por: Korman, Tony M.
Publicado: (2021) -
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection
por: McCullough, Peter A., et al.
Publicado: (2021) -
Rapid antigen tests for the detection of SARS-CoV-2: A comment
por: Sookaromdee, Pathum, et al.
Publicado: (2022)